Oliver Harris, 9 months, cries after receiving a vaccine against the coronavirus disease at Northwell Health's Cohen Children's Medical Center in New Hyde Park, New York, U.S., June 22, 2022.
Oliver Harris, 9 months, cries after receiving a vaccine against the coronavirus disease at Northwell Health's Cohen Children's Medical Center in New Hyde Park, New York, U.S., June 22, 2022. REUTERS/Shannon StapletonThe Food and Drug Administration on Thursday authorized updated Covid shots that target the omicron variant for children as young as 6 months old.
Children 6 months through 5 years old who received Moderna's original vaccines are now eligible for an omicron booster two months after finishing their primary series. Kids ages 6 months through 4 years old who have not yet started Pfizer's three-dose primary series are eligible to receive an omicron shot as their third dose.
But kids in the same age group who have already completed Pfizer's three-dose primary series cannot get the omicron shot as a booster at this time.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Inquest will examine UK's first-known child Covid-19 deathThe coroner hears 13-year-old Ismail's breathing tube might not have been fitted correctly.
Consulte Mais informação »
Netflix's 'Wednesday' Slammed After Jenna Ortega Reveals She Shot Dance Scene While Sick with COVID'I felt like I'd been hit by a car and that a little goblin had been let loose in my throat and was scratching the walls of my esophagus,' Ortega recalled of filming the viral scene while sick.
Consulte Mais informação »
4 financial moves if you have — or are worried about — long CovidHouseholds can manage or plan for the financial impact of long Covid via insurance, health, tax and estate planning.
Consulte Mais informação »
The flu, COVID-19 and RSV: Why health experts are concerned about this ‘tripledemic’Hospitals are filling up with people battling both flu and COVID as well as with pediatric patients suffering from RSV. This is what health experts have deemed as the ‘tripledemic’ and there’s concern that these infections will continue to spread.
Consulte Mais informação »
Pfizer partners with Clear Creek Bio to develop oral COVID-19 drugPfizer Inc and Clear Creek Bio Inc on Tuesday announced a collaboration to identify a potential drug candidate and develop a new class of oral treatment against COVID-19, as Pfizer seeks to expand its anti-infective pipeline.
Consulte Mais informação »